Role of Homoeopathic Individualized Medicine in the management of Post Menopausal Syndrome
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Change in clinical signs and symptoms
研究概览
简要总结
ROLE OF HOMOEOPATHIC INDIVIDUALIZED MEDICINE IN THE MANAGEMENT OF POST MENOPAUSAL SYNDROME.
Menopause is defined retrospectively as the time of the final menstrual period, followed by 12 months of amenorrhea. Post-menopause describes the period following the final menses. Menopause (ICD-11 GA30. 00) is the permanent cessation of menstruation resulting in the loss of ovarian follicle development. Post-menopause syndrome can often go unrecognized, with many patients dismissing its symptoms as just a normal part of aging, unaware of its potential impact on their well-being. Unbeknownst to many, post-menopause syndrome encompasses a range of symptoms, including hot flashes, mood swings, fatigue, and changes in libido, among others. Ignoring these signs can lead to unnecessary discomfort and affect one’s quality of life. Seeking medical guidance and support can empower individuals to better manage these symptoms and enjoy a healthier post-menopausal journey.The Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ) is a tool designed to assess satisfaction with treatments for menopausal symptoms. It typically consists of questions related to the effectiveness of treatments, their side effects, ease of use, and overall satisfaction.In conclusion, studying the role of homoeopathic individualized medicine in the management of postmenopausal syndrome is to justify the need for safe, effective, and personalized treatment options that address the diverse symptoms experienced by women during this transitional phase of life. Such research has the potential to contribute to a more comprehensive understanding of complementary and alternative approaches to women’s health and improve patient-centered care in the management of postmenopausal symptoms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 45.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- Female
入选标准
- •Females who have attained menopause and are above 45 are included Climacteric female suffering from postmenopausal syndrome are included Complications due to menopause are included.
排除标准
- •Females affected with other systemic and autoimmune illness are excluded Females undergone hysterectomy and oophorectomy are not included Female psychiatric illness is excluded.
结局指标
主要结局
Change in clinical signs and symptoms
时间窗: Minimum period of 6 months and maximum period of 1 year
次要结局
- Reduction in The Menopause-Specific Quality of Life Questionnaire (MENQOL)(Change in general wellbeing & mental state)
研究者
Mahalakshumi H
White Memorial Homoeopathic Medical College and Hospital
